NOS3 and coronary artery disorder: On the contrary, the lipid-lowering medication statins widely prescribed for the treatment of coronary heart disease (CHD) can stimulate eNOS activity and NO production by stabilizing NOS3 mRNA without altering transcription (Forbes and Newsome, 2016).